Ambipar Emergency Financials

Trends View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ambipar Emergency Stock Summary

Ambipar Emergency competes with Agilyx AS, BQE Water, Anaergia, Avalon Holdings, and LanzaTech Global. Ambit Biosciences Corporationration, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States.

Ambipar Emergency Key Financial Ratios

Ambipar Emergency Key Balance Sheet Accounts

Ambipar Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ambipar Emergency's current stock value. Our valuation model uses many indicators to compare Ambipar Emergency value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ambipar Emergency competition to find correlations between indicators driving Ambipar Emergency's intrinsic value. More Info.Ambipar Emergency Response is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about  0.63  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ambipar Emergency Response is roughly  1.58 . As of now, Ambipar Emergency's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ambipar Emergency's earnings, one of the primary drivers of an investment's value.

Ambipar Emergency Systematic Risk

Today, most investors in Ambipar Emergency Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ambipar Emergency's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ambipar Emergency growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ambipar Emergency help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ambipar Emergency Response. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ambipar Emergency Response based on widely used predictive technical indicators. In general, we focus on analyzing Ambipar Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ambipar Emergency's daily price indicators and compare them against related drivers.

When running Ambipar Emergency's price analysis, check to measure Ambipar Emergency's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ambipar Emergency is operating at the current time. Most of Ambipar Emergency's value examination focuses on studying past and present price action to predict the probability of Ambipar Emergency's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ambipar Emergency's price. Additionally, you may evaluate how the addition of Ambipar Emergency to your portfolios can decrease your overall portfolio volatility.